$27.46
-1.01[-3.55%]
At close: Apr 25
$27.46
0[0.00%]
After Hours: 4:00PM EDT
Genmab Stock (NASDAQ:GMAB), Earnings Estimates, EPS, and Revenue
Genmab reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$0.140
Quarterly Revenue Estimate
$595.5M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$16.5B
Analyze the earnings history of Genmab using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | AM | GMAB | Q1 | $0.05 | $0.14 | — | — | $411.34M | $595.53M | — | — | Get Alert |
| 02/14/2024 | AM | GMAB | Q4 | $0.12 | $4.02 | $0.36 | -91.04% | $699.51M | $679.55M | $675.05M | -0.66% | Get Alert |
| 11/07/2023 | AM | GMAB | Q3 | $0.53 | — | $0.47 | — | $553.75M | $630.48M | $692.70M | 9.87% | Get Alert |
| 08/03/2023 | AM | GMAB | Q2 | $0.41 | $0.31 | $0.30 | -2.90% | $453.01M | $618.77M | $613.49M | -0.85% | Get Alert |
| 05/10/2023 | AM | GMAB | Q1 | $0.11 | $0.65 | $0.05 | -92.31% | $319.67M | $417.90M | $411.34M | -1.57% | Get Alert |
| 02/22/2023 | AM | GMAB | Q4 | $0.17 | $3.18 | $0.12 | -96.23% | $402.80M | $664.17M | $699.51M | 5.32% | Get Alert |
| 11/09/2022 | AM | GMAB | Q3 | $0.21 | $1.63 | $0.53 | -67.48% | $366.37M | $475.35M | $553.75M | 16.49% | Get Alert |
| 08/10/2022 | AM | GMAB | Q2 | $0.08 | $1.58 | $0.41 | -74.05% | $319.46M | $404.75M | $453.01M | 11.92% | Get Alert |
| 05/11/2022 | AM | GMAB | Q1 | $0.27 | — | $0.11 | — | $256.28M | $319.59M | $319.67M | 0.02% | Get Alert |
| 02/16/2022 | AM | GMAB | Q4 | $0.14 | — | $0.17 | — | $327.45M | — | $402.80M | — | Get Alert |
| 11/10/2021 | AM | GMAB | Q3 | $0.13 | — | $0.21 | — | $270.67M | $319.59M | $366.37M | 14.64% | Get Alert |
| 08/11/2021 | AM | GMAB | Q2 | $0.76 | — | $0.08 | — | $804.57M | — | $319.46M | — | Get Alert |
| 05/05/2021 | AM | GMAB | Q1 | $0.06 | $0.23 | $0.27 | 17.39% | $131.66M | $207.51M | $256.28M | 23.50% | Get Alert |
| 02/23/2021 | AM | GMAB | Q4 | $0.34 | $1.17 | $0.14 | -88.03% | $444.15M | $303.75M | $327.45M | 7.80% | Get Alert |
| 11/04/2020 | PM | GMAB | Q3 | $0.12 | $0.91 | $0.13 | -85.71% | $155.98M | $247.63M | $270.67M | 9.30% | Get Alert |
| 08/12/2020 | PM | GMAB | Q2 | $0.02 | — | $0.76 | — | $115.61M | — | $804.57M | — | Get Alert |
| 05/06/2020 | PM | GMAB | Q1 | — | — | $0.06 | — | — | — | $131.66M | — | Get Alert |
| 02/19/2020 | PM | GMAB | Q4 | — | $3.37 | $0.34 | -89.91% | — | $390.98M | $444.15M | 13.60% | Get Alert |
| 11/06/2019 | PM | GMAB | Q3 | — | $0.64 | $0.12 | -81.25% | — | $128.75M | $155.98M | 21.15% | Get Alert |
FAQ
When is Genmab (NASDAQ:GMAB) reporting earnings?
Genmab (GMAB) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 14, 2024 for Q4.
What were the latest earnings per share (EPS) for Genmab (NASDAQ:GMAB)?
The Actual EPS was $0.36, which missed the estimate of $4.02.
What were Genmab’s (NASDAQ:GMAB) revenues?
The Actual Revenue was $675M, which missed the estimate of $679.5M.
Browse earnings estimates, EPS, and revenue on all stocks.